过敏症医生、皮肤科医生和儿科医生治疗特应性皮炎的不同方法。

IF 1.5 Q3 DERMATOLOGY
Dermatology Research and Practice Pub Date : 2021-12-03 eCollection Date: 2021-01-01 DOI:10.1155/2021/6050091
Suzieni Padoin Zuccolo de Bortoli, Herberto José Chong Neto, Nelson Augusto Rosário Filho
{"title":"过敏症医生、皮肤科医生和儿科医生治疗特应性皮炎的不同方法。","authors":"Suzieni Padoin Zuccolo de Bortoli, Herberto José Chong Neto, Nelson Augusto Rosário Filho","doi":"10.1155/2021/6050091","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disease, with a vast drug arsenal and guidelines available for its management and diagnosis and different medical specialties engaged in providing care. This study aimed to outline the therapeutic and diagnostic approaches to the AD of allergists, dermatologists, and pediatricians and verify whether they are compliant with the guidelines.</p><p><strong>Methods: </strong>A cross-sectional study using an electronic questionnaire administered through the SurveyMonkey® platform was disclosed by participating medical societies to their medical associates.</p><p><strong>Results: </strong>Of the 1,473 participating physicians, the use of moisturizers as part of AD treatment was observed among pediatricians (91.9%), dermatologists (97.5%), and allergists (100%; <i>p</i>=0.07). The preference for the use of new emollients was lower among pediatricians (57%) than dermatologists (75.9%) and allergists (71.4%; <i>p</i> < 0.001). The prevalence of wet-wrap therapy was lower among dermatologists (16.3%) than allergists (51%; <i>p</i> < 0.001). The recommendation of proactive treatment with topical corticosteroids was more frequently reported by allergists (65.3%) than pediatricians (43.3%) and dermatologists (40.8%; <i>p</i> < 0.001), and the same trend was observed in relation to proactive treatment using calcineurin inhibitors. The use of oral anti-histamines to control pruritus was mainly considered by pediatricians (69.2%) and dermatologists (59.2% <i>p</i> < 0.001). Clinical experience with systemic immunomodulating agents was greater among allergists (77.5%) and dermatologists (60.8%; <i>p</i> < 0.001), with cyclosporine being the most cited systemic immunomodulating agent. Environmental control of aeroallergens was recommended by pediatricians (89.8%), dermatologists (86.9%), and allergists (100%; <i>p</i>=0.01).</p><p><strong>Conclusion: </strong>There were differences in the therapeutic and diagnostic approaches to AD used by allergists, dermatologists, and pediatricians and those recommended by the guidelines, especially regarding the use of wet-wrap therapy, proactive treatment with topical corticosteroids or calcineurin inhibitors, prescription of anti-histamines, recommendation of phototherapy, and control of aeroallergens.</p>","PeriodicalId":11338,"journal":{"name":"Dermatology Research and Practice","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664543/pdf/","citationCount":"0","resultStr":"{\"title\":\"Different Approaches to Atopic Dermatitis by Allergists, Dermatologists, and Pediatricians.\",\"authors\":\"Suzieni Padoin Zuccolo de Bortoli, Herberto José Chong Neto, Nelson Augusto Rosário Filho\",\"doi\":\"10.1155/2021/6050091\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disease, with a vast drug arsenal and guidelines available for its management and diagnosis and different medical specialties engaged in providing care. This study aimed to outline the therapeutic and diagnostic approaches to the AD of allergists, dermatologists, and pediatricians and verify whether they are compliant with the guidelines.</p><p><strong>Methods: </strong>A cross-sectional study using an electronic questionnaire administered through the SurveyMonkey® platform was disclosed by participating medical societies to their medical associates.</p><p><strong>Results: </strong>Of the 1,473 participating physicians, the use of moisturizers as part of AD treatment was observed among pediatricians (91.9%), dermatologists (97.5%), and allergists (100%; <i>p</i>=0.07). The preference for the use of new emollients was lower among pediatricians (57%) than dermatologists (75.9%) and allergists (71.4%; <i>p</i> < 0.001). The prevalence of wet-wrap therapy was lower among dermatologists (16.3%) than allergists (51%; <i>p</i> < 0.001). The recommendation of proactive treatment with topical corticosteroids was more frequently reported by allergists (65.3%) than pediatricians (43.3%) and dermatologists (40.8%; <i>p</i> < 0.001), and the same trend was observed in relation to proactive treatment using calcineurin inhibitors. The use of oral anti-histamines to control pruritus was mainly considered by pediatricians (69.2%) and dermatologists (59.2% <i>p</i> < 0.001). Clinical experience with systemic immunomodulating agents was greater among allergists (77.5%) and dermatologists (60.8%; <i>p</i> < 0.001), with cyclosporine being the most cited systemic immunomodulating agent. Environmental control of aeroallergens was recommended by pediatricians (89.8%), dermatologists (86.9%), and allergists (100%; <i>p</i>=0.01).</p><p><strong>Conclusion: </strong>There were differences in the therapeutic and diagnostic approaches to AD used by allergists, dermatologists, and pediatricians and those recommended by the guidelines, especially regarding the use of wet-wrap therapy, proactive treatment with topical corticosteroids or calcineurin inhibitors, prescription of anti-histamines, recommendation of phototherapy, and control of aeroallergens.</p>\",\"PeriodicalId\":11338,\"journal\":{\"name\":\"Dermatology Research and Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2021-12-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664543/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatology Research and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2021/6050091\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/6050091","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:特应性皮炎(AD)是最普遍的慢性炎症性皮肤病,有大量的药物和指南可用于治疗和诊断,并有不同的专科医师提供护理。本研究旨在概述过敏症专科医生、皮肤科医生和儿科医生对过敏性皮炎的治疗和诊断方法,并验证他们是否遵守了相关指南:方法:参与研究的医疗协会向其医疗协会成员公布了一项横断面研究,通过 SurveyMonkey® 平台进行电子问卷调查:结果:在 1473 名参与调查的医生中,儿科医生(91.9%)、皮肤科医生(97.5%)和过敏科医生(100%;P=0.07)将保湿剂作为 AD 治疗的一部分。儿科医生(57%)对使用新型润肤剂的偏好低于皮肤科医生(75.9%)和过敏科医生(71.4%;P <0.001)。皮肤科医生(16.3%)采用湿敷疗法的比例低于过敏专科医生(51%;P < 0.001)。过敏专科医生(65.3%)比儿科医生(43.3%)和皮肤科医生(40.8%;P < 0.001)更多地建议使用局部皮质类固醇激素进行积极治疗,在使用钙化蛋白抑制剂进行积极治疗方面也观察到同样的趋势。儿科医生(69.2%)和皮肤科医生(59.2%,P < 0.001)主要考虑使用口服抗组胺药来控制瘙痒。过敏症医生(77.5%)和皮肤科医生(60.8%;P < 0.001)对全身性免疫调节药物的临床经验更丰富,其中环孢素是最常用的全身性免疫调节药物。儿科医生(89.8%)、皮肤科医生(86.9%)和过敏科医生(100%;P=0.01)都建议对空气过敏原进行环境控制:过敏专科医生、皮肤科医生和儿科医生对过敏性鼻炎采用的治疗和诊断方法与指南推荐的方法存在差异,尤其是在使用湿敷疗法、使用外用皮质类固醇激素或钙化蛋白抑制剂进行前瞻性治疗、开具抗组胺药处方、推荐光疗和控制空气过敏原方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Different Approaches to Atopic Dermatitis by Allergists, Dermatologists, and Pediatricians.

Different Approaches to Atopic Dermatitis by Allergists, Dermatologists, and Pediatricians.

Objectives: Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disease, with a vast drug arsenal and guidelines available for its management and diagnosis and different medical specialties engaged in providing care. This study aimed to outline the therapeutic and diagnostic approaches to the AD of allergists, dermatologists, and pediatricians and verify whether they are compliant with the guidelines.

Methods: A cross-sectional study using an electronic questionnaire administered through the SurveyMonkey® platform was disclosed by participating medical societies to their medical associates.

Results: Of the 1,473 participating physicians, the use of moisturizers as part of AD treatment was observed among pediatricians (91.9%), dermatologists (97.5%), and allergists (100%; p=0.07). The preference for the use of new emollients was lower among pediatricians (57%) than dermatologists (75.9%) and allergists (71.4%; p < 0.001). The prevalence of wet-wrap therapy was lower among dermatologists (16.3%) than allergists (51%; p < 0.001). The recommendation of proactive treatment with topical corticosteroids was more frequently reported by allergists (65.3%) than pediatricians (43.3%) and dermatologists (40.8%; p < 0.001), and the same trend was observed in relation to proactive treatment using calcineurin inhibitors. The use of oral anti-histamines to control pruritus was mainly considered by pediatricians (69.2%) and dermatologists (59.2% p < 0.001). Clinical experience with systemic immunomodulating agents was greater among allergists (77.5%) and dermatologists (60.8%; p < 0.001), with cyclosporine being the most cited systemic immunomodulating agent. Environmental control of aeroallergens was recommended by pediatricians (89.8%), dermatologists (86.9%), and allergists (100%; p=0.01).

Conclusion: There were differences in the therapeutic and diagnostic approaches to AD used by allergists, dermatologists, and pediatricians and those recommended by the guidelines, especially regarding the use of wet-wrap therapy, proactive treatment with topical corticosteroids or calcineurin inhibitors, prescription of anti-histamines, recommendation of phototherapy, and control of aeroallergens.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.80
自引率
0.00%
发文量
16
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信